Biomarker Guided Treatment in DLBCL

Clinical trial NCT04025593 · UNKNOWN

Trial details

NCT number: NCT04025593
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma

Start date: 2019-07-17
Primary completion: 2021-07-01
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.